MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
451.23%
Quick Ratio
451.23%
Debt to Asset Ratio
26.79%
Unit: Dollar
Assets Breakdown
    • Cash
    • Prepaid expenses and other curre...
    • Other assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
27,595,831
34,413,110
8,658,031
10,891,736
Prepaid expenses and other current assets
641,540
902,017
1,043,825
780,515
Australia research and development incentives receivable
-
-
-
82,685
Total current assets
28,237,371
35,315,127
9,701,856
11,754,936
Other assets
2,800
7,518
2,800
27,085
Total assets
28,240,171
35,322,645
9,704,656
11,782,021
Accounts payable
2,838,652
2,983,058
2,038,803
3,175,641
Accrued expenses
3,419,240
3,339,379
3,797,595
6,818,803
Total current liabilities
6,257,892
6,322,437
5,836,398
9,994,444
Warrant liability
1,307,269
1,237,440
1,492,395
1,745,907
Total liabilities
7,565,161
7,559,877
7,328,793
11,740,351
Common stock, 0.0001 par value, 150,000,000 shares authorized at june 30, 2026 and at december 31, 2025, respectively, 60,817,482 and 38,624,289 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
6,082
6,068
3,863
3,446
Additional paid-in capital
144,654,861
143,797,024
112,053,233
106,071,303
Accumulated deficit
-123,944,244
-116,000,657
-109,631,005
-106,002,244
Accumulated other comprehensive loss
-41,689
-39,667
-50,228
-30,835
Total stockholders equity
20,675,010
27,762,768
2,375,863
41,670
Total liabilities and stockholders equity
28,240,171
35,322,645
9,704,656
11,782,021
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$27,595,831 (172.03%↑ Y/Y)Prepaid expenses andother current assets$641,540 (-21.40%↓ Y/Y)Total current assets$28,237,371 (155.70%↑ Y/Y)Other assets$2,800 (0.00%↑ Y/Y)Total assets$28,240,171 (155.66%↑ Y/Y)Total liabilities andstockholders equity$28,240,171 (155.66%↑ Y/Y)Total stockholdersequity$20,675,010 (433.32%↑ Y/Y)Total liabilities$7,565,161 (5.52%↑ Y/Y)Accumulated deficit-$123,944,244 (-27.65%↓ Y/Y)Accumulated othercomprehensive loss-$41,689 (-38.83%↓ Y/Y)Additional paid-in capital$144,654,861 (43.22%↑ Y/Y)Total currentliabilities$6,257,892 (24.07%↑ Y/Y)Warrant liability$1,307,269 (-38.49%↓ Y/Y)Common stock, 0.0001par value,...$6,082 (91.14%↑ Y/Y)Accrued expenses$3,419,240 (2.96%↑ Y/Y)Accounts payable$2,838,652 (64.73%↑ Y/Y)

MAIA Biotechnology, Inc. (MAIA)

MAIA Biotechnology, Inc. (MAIA)